Cardinal Health, Inc. (CAH) Receives Average Recommendation of “Hold” from Analysts
Shares of Cardinal Health, Inc. (NYSE:CAH) have received a consensus rating of “Hold” from the twenty analysts that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $80.66.
A number of equities analysts have weighed in on the stock. Jefferies Group LLC assumed coverage on shares of Cardinal Health in a research note on Wednesday, May 17th. They issued a “hold” rating and a $77.00 target price for the company. ValuEngine downgraded shares of Cardinal Health from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Evercore ISI reaffirmed an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, July 4th. Zacks Investment Research raised shares of Cardinal Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 20th. Finally, Vetr raised shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 target price for the company in a research note on Tuesday, June 13th.
Cardinal Health (NYSE:CAH) traded down 1.01% on Friday, hitting $68.36. 1,843,590 shares of the company were exchanged. Cardinal Health has a one year low of $62.70 and a one year high of $84.88. The firm has a market cap of $21.63 billion, a price-to-earnings ratio of 16.96 and a beta of 0.85. The stock has a 50 day moving average price of $69.50 and a 200 day moving average price of $75.51.
Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.07. The firm had revenue of $32.97 billion for the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.14 earnings per share. On average, equities research analysts forecast that Cardinal Health will post $4.96 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Investors of record on Monday, October 2nd will be paid a dividend of $0.4624 per share. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.71%. The ex-dividend date of this dividend is Friday, September 29th. Cardinal Health’s dividend payout ratio (DPR) is 45.79%.
Large investors have recently modified their holdings of the business. Bronfman E.L. Rothschild L.P. increased its stake in Cardinal Health by 31.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock valued at $123,000 after purchasing an additional 382 shares in the last quarter. Advisory Services Network LLC increased its stake in Cardinal Health by 18.4% in the second quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock valued at $136,000 after purchasing an additional 270 shares in the last quarter. JFS Wealth Advisors LLC increased its stake in Cardinal Health by 14.3% in the second quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock valued at $152,000 after purchasing an additional 244 shares in the last quarter. Dupont Capital Management Corp bought a new stake in Cardinal Health in the second quarter valued at approximately $164,000. Finally, First Personal Financial Services increased its stake in Cardinal Health by 127.5% in the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock valued at $172,000 after purchasing an additional 1,238 shares in the last quarter. 87.68% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: This article was posted by American Banking News and is the property of of American Banking News. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/09/09/cardinal-health-inc-cah-receives-average-recommendation-of-hold-from-analysts.html.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.